Alliance Pharma PLC Directorate Changes (8511L)
May 18 2022 - 10:07AM
UK Regulatory
TIDMAPH
RNS Number : 8511L
Alliance Pharma PLC
18 May 2022
For immediate release 18 May 2022
ALLIANCE PHARMA
("Alliance" or the "Group")
Directorate changes
Alliance Pharma plc (AIM: APH), the international healthcare
group, announces that, in line with good corporate governance,
David Cook, Alliance's Chair, will be stepping down next year,
following the AGM in May 2023, after serving on the Board for nine
years.
Jo LeCouilliard, currently a Non-Executive Director on the Board
of Alliance, will become Chair following the AGM in May 2023.
Jo LeCouilliard joined Alliance as a Non-Executive Director on 1
January 2019. She brings over 25 years of international healthcare
management experience through her career at GlaxoSmithKline where,
amongst other roles, she headed the US vaccines business and the
Asia Pacific Pharmaceuticals business. Jo is a Chartered Accountant
and is currently a Non-Executive Director at Circassia Group plc,
Indivior plc and Recordati S.p.a.
David Cook commented: "Alliance has developed significantly over
the time I have been with the business, building an international
footprint and transitioning to focus on consumer healthcare brands.
I am confident that the Company has a bright future, led by an
outstanding senior management team. Jo has been an invaluable Board
member over the past three and a half years and we are delighted
that she has agreed to chair the Board as the Company continues on
its growth trajectory. I look forward to working closely with her
during my remaining time at Alliance."
Jo LeCouilliard commented: "I am delighted to be taking on the
position of Chair following next year's AGM. I have been really
impressed by Alliance's strong management team and strategy over my
last three and a half years on the Board. The Company has
successfully executed a number of strategic consumer healthcare
acquisitons and has built a solid international infrastructure. I
look forward to leading the Board in taking the Company
forward."
For further information:
Alliance Pharma plc + 44 (0)1249 466966
Cora McCallum, Head of Investor Relations
& Corporate Communications + 44 (0)1249 705168
ir@allianceph.com
+ 44 (0)20 7466
Buchanan 5000
Mark Court / Sophie Wills / Hannah Ratcliff
alliancepharma@buchanan.uk.com
+ 44 (0)20 7260
Numis Securities Limited 1000
Nominated Adviser: Freddie Barnfield / Duncan
Monteith
Corporate Broking: James Black
+ 44 (0)20 7597
Investec Bank plc 5970
Corporate Finance: Daniel Adams
Corporate Broking: Patrick Robb
About Alliance
Alliance Pharma plc (AIM: APH) is an international healthcare
group. Our purpose is to improve the lives of consumers and
patients through making available a range of clinically valuable
healthcare products.
Our core focus is on the marketing of Consumer Healthcare
brands, complemented by a smaller Prescription Medicines business.
In total, we hold marketing rights to around 80 brands, with
revenues generated from a mix of direct, distributor and e-commerce
sales.
Headquartered in the UK, the Group employs around 250 people
based in locations across Europe, North America, and the Asia
Pacific region. By outsourcing our manufacturing and logistics
operations, we remain asset-light and focused on maximising the
value of our brands.
For more information on Alliance, please visit our website :
www.alliancepharmaceuticals.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAGPUWWAUPPGMM
(END) Dow Jones Newswires
May 18, 2022 10:07 ET (14:07 GMT)
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2024 to May 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From May 2023 to May 2024